In the FLOW trial, researchers assessed whether the glucagon-like peptide 1 receptor agonist semaglutide was effective in preventing progression of kidney disease in patients with type 2 diabetes and chronic kidney disease. Full trial results: nej.md/44U3slP

Un texte passionnant sur le parcours semé d’embûches (pour le moins) de la démocratie en santé en néphrologie. (Et il est en accès libre !) ⬇️

The UK eCKD Guide has now been updated. This important resource is derived from NICE #CKD guidelines & relevant UKKA guidelines. It provides quick online support for the diagnosis & management of chronic #kidney disease. Access now ➡️ bit.ly/468tRNr

Advancing Genetic Testing in Kidney Diseases: Report From a National Kidney Foundation Working Group buff.ly/4d5DvDj (FREE) Nora Franceschini Alex Chang, MD, FASN, FAHA Neera Dahl Hila Milo Rasouly NKF Nephrology Professionals

Two recent studies emphasized the value of early #CKD screening, showing that early detection enables prompt treatment, cuts the need for costly interventions and reduces future health risks. Read more by Navdeep Tangri, MD, PhD, FRCP: bit.ly/3WymiuW

Facts and myths about altruistic organ donation doi.org/10.1093/ndt/gf… In the opinion of the authors, the benefits of altruistic kidney donation exceed the disadvantages; hence, initiatives to increase altruistic donorship are urgently needed.

New study examines how pre-emptive kidney transplant rates have evolved over time & what barriers still need to be overcome. Using data from ERA Registry with contributions from the UKRR the analysis sheds light on potential initiatives. Read more: education.ukkidney.org/blog/pre-empti…

Characteristics of the first immunocompromised patients to receive sipavibart as an early access treatment for COVID-19 pre-exposure prophylaxis in France dlvr.it/TBxc5N #LongCovid #pwLC

Escape of #SARS-CoV-2 KP1.1, LB.1 and KP3.3 from recently approved monoclonal antibodies. #Pemivibart/VYD222 is less efficient, #Sipavibart/ AZD3152 no longer neutralizes KP1.1, LB.1, and KP3.3 in cell systems. Congrats to Planas Delphine and coll.! biorxiv.org/content/10.110…

Now open access in NDT Adult outcomes of childhood dialysis/KT in Europe from 2008 to 2019: an ERA Registry study 🧐Life expectancy for 18Y-old KT and dialysis pts was 17Y and 40Y shorter compared to the general population, respectively. ▶️academic.oup.com/ndt/article/do…

📰 [1/5] Communiqué de presse | EPI-PHARE publie dans JAMA les résultats d'une étude sur le pronostic à 18 mois des myocardites attribuables à la vaccination ARNm contre la COVID-19. #SNDS 🔗 epi-phare.fr/actualites/com…

Latest publication of our team EPI-PHARE in JAMA about long-term prognosis of patients with myocarditis attributed Covid-19 mRNA vaccination

A comparison of the epidemiology of kidney replacement therapy between Europe & the US The US had a much higher KRT incidence, prevalence, & mortality compared to Europe doi.org/10.1093/ndt/gf…

The risk for perioperative mortality in living kidney donors has significantly reduced in the past decade, a study showed. medscape.com/viewarticle/ki…

77 days. That was the total survival advantage of dialysis compared to no dialysis in veterans over the age of 65. Oh, and by the way, that 77 extra days was associated with 14 less days at home Stunning.